DSM Pharmaceutical Products’ unit, DSM Biologics, has collaborated with Upfront Chromatography A/S to optimize Upfront’s new, fully disposable chromatography system for use with DSM’s proprietary manufacturing technology. The fully integrated disposable chromatography system will offer biopharmaceutical manufacturers significant efficiency and productivity benefits and is expected to be available for commercial use by the summer of 2008. The flexible, easy-to-use and high capacity bioprocessing platform can be scaled from 0.1L to 100L for commercial manufacture and recovery of a range of biopharmaceuticals, including monoclonal antibodies.